AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2020
Dec 11, 2020
3133_iss_2020-12-11_2f6ea324-699a-4acd-abde-2cb04d01f11e.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Issuer Active Biotech AB (publ)
Holder
Nordstjernan Aktiebolag
Instrument
| Instrument | Aktie SE0001137985 |
|---|---|
| Before the transaction | |
| Shares | 8,508,541 |
| Voting rights | 8,508,541 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 11/12/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 7,133,107 |
| Directly held voting rights | 7,133,107 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.91 % |
| Directly held voting rights | 4.91 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 4.91 % | 7,133,107 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
|||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | 4.91 % | 7,133,107 | |
| Group total holdings | |||
| Voting rights | 7,133,107 | ||
| Percentage of voting rights 4.91 | |||
| Published | |||
| 11/12/2020 14:02 | |||
| Contact | |||
| Name | Mats Liljegren | ||
| Phone 070-3067868 Email [email protected] |
|||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Quarterly Report
2026
May 7
Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 17
Annual Report (ESEF)
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30
Share Issue/Capital Change
2026
Jan 30
Regulatory Filings
2026
Jan 21